http://www.eurofins.dk/en/pharma-rss-feed.aspxWed, 18 Apr 2012 13:57:50 GMThttp://umbraco.orgen-GBwebmaster@eurofins.com (Eurofins webmaster) ( General contact address for Eurofins ) http://www.eurofins.com/media/65633/eurofinslogo8bit.pnghttp://www.eurofins.dk/en/pharma-rss-feed.aspxhttp://www.eurofins.dk/en/pharma/news/eurofins-pharma-as-moving-to-a-new-location.aspxWed, 18 Apr 2012 13:57:50 GMTPharmahttp://www.eurofins.dk/en/pharma/news/eurofins-pharma-as-moving-to-a-new-location.aspxWe move our site from the rented location Strandesplanaden 110, Vallensbæk Strand to our own property Ørnebjergvej 1, Glostrup on Monday 21 May 2012http://www.eurofins.dk/en/pharma/news/validated-microseq-dna-sequencing-of-bacteria,-yeast-or-fungi-for-pharmaceutical-companies.aspxThu, 06 Jan 2011 13:27:39 GMTPharmahttp://www.eurofins.dk/en/pharma/news/validated-microseq-dna-sequencing-of-bacteria,-yeast-or-fungi-for-pharmaceutical-companies.aspxEurofins Microbial – ID Packs purchase option provides an additional reduction of the unit price of each test and drastically simplifies internal management and logistics, providing a very efficient solution for strains’ shipment with all the disposables materials included into the final price. http://www.eurofins.dk/en/pharma/news/reduced-delivery-time---nvoc.aspxWed, 15 Sep 2010 11:22:07 GMTPharmahttp://www.eurofins.dk/en/pharma/news/reduced-delivery-time---nvoc.aspxEurofins Pharma reduces delivery time for chemical analysis of water samples from 10 to 3 working days following client requests for faster answers. The improved delivery time is the result of 12 months streamlining efforts in the chemical labhttp://www.eurofins.dk/en/pharma/news/newsletter---enlarged-services-for-stability-studies.aspxMon, 07 Dec 2009 12:51:17 GMTPharmahttp://www.eurofins.dk/en/pharma/news/newsletter---enlarged-services-for-stability-studies.aspxThe stability of a product’s primary packaging, its active substances and the properties of the drug formulation is basic qualities and characteristics that must be evaluated. This is done after the product has been stored under different environmental conditionshttp://www.eurofins.dk/en/pharma/news/newsletter---eurofins-supports-the-chemical,-disinfectants-and-antiseptics-industries-in-the-global-fight-against-swine-flu.aspxMon, 09 Nov 2009 16:02:49 GMTPharmahttp://www.eurofins.dk/en/pharma/news/newsletter---eurofins-supports-the-chemical,-disinfectants-and-antiseptics-industries-in-the-global-fight-against-swine-flu.aspxEurofins is pleased to announce that it has now completed the validation process for the testing of virucidal efficacy of disinfectants and other biocidal products specifically for use in the worldwide fight against the H1N1 virus and has started to carry out the first tests. A successful test would therefore allow Eurofins’ customers to be able to label the product as having “Efficacy against H1N1”. The test has further applications for other viruses, such as Hepatitis, Polio, Novoviruses and HIVhttp://www.eurofins.dk/en/pharma/news/newsletter---an-easy-way-to-fast--reliable-sugar-analyses.aspxFri, 30 Oct 2009 11:54:03 GMTPharmahttp://www.eurofins.dk/en/pharma/news/newsletter---an-easy-way-to-fast--reliable-sugar-analyses.aspxAll manufacturers in the pharmaceutical industry use sugars or sugar derivatives as raw materials in the production of tablets, capsules and oral liquids. Eurofins Pharma A/S has built up extensive expertise in sugar analyses according to Ph.Eur. and USP....http://www.eurofins.dk/en/pharma/news/newsletter---increased-demand-for-detection-of-heavy-metals.aspxThu, 27 Aug 2009 15:17:49 GMTPharmahttp://www.eurofins.dk/en/pharma/news/newsletter---increased-demand-for-detection-of-heavy-metals.aspxA USP working group recommends modification of the analytical methods for detection of heavy metals. New default procedures (ICP-OES and ICPMS) will be introduced. The present limit tests described in will be phased out over a not yet defined period.http://www.eurofins.dk/en/pharma/news/newsletter---positive-audit-by-fda.aspxWed, 03 Jun 2009 12:39:52 GMTPharmahttp://www.eurofins.dk/en/pharma/news/newsletter---positive-audit-by-fda.aspxFDA, KFDA, Brasilian health authorities, and the Danish Medical Agency have during the last eight months audited Eurofins Pharmahttp://www.eurofins.dk/en/pharma/news/pheurusp.aspxTue, 31 Mar 2009 13:00:22 GMTPharmahttp://www.eurofins.dk/en/pharma/news/pheurusp.aspxThe European Pharmacopoeia and the U.S. Pharmacopeia has been harmonised and Eurofins Pharma is ready